RxSight, Inc. Gain (Loss) on Extinguishment of Debt
RxSight, Inc. (RXST) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-25
- RxSight, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- RxSight, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- RxSight, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $0.00.
- RxSight, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- RxSight, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was $0.00.
- RxSight, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- RxSight, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$1.77M.
- RxSight, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.41M derived: sum of 2 quarters · filed 2026-02-25 | -$1.77M derived: sum of 3 quarters · filed 2026-02-25 | -$1.77M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.41M 10-Q · filed 2024-11-07 | -$1.77M derived: sum of 2 quarters · filed 2024-11-07 | -$1.77M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$362.00K 10-Q · filed 2024-08-05 | -$362.00K 10-Q · filed 2024-08-05 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |